Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 161,275 | 151,794 | 354,643 | 107,736 | 119,445 |
| Marketable Securities | 776,529 | 847,123 | 699,149 | 730,254 | 778,733 |
| Receivables | 286 | 306 | 241 | 288 | 269 |
| Other current assets | 9,030 | 8,172 | 16,456 | 4,764 | 4,677 |
| TOTAL | $958,388 | $1,019,505 | $1,087,297 | $855,793 | $915,787 |
| Non-Current Assets | |||||
| PPE Net | 11,950 | 11,634 | 11,390 | 8,922 | 8,904 |
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 64,922 | 66,332 | 67,731 | 22,406 | 22,887 |
| TOTAL | $79,172 | $80,266 | $81,421 | $33,628 | $34,091 |
| Total Assets | $1,037,560 | $1,099,771 | $1,168,718 | $889,421 | $949,878 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,834 | 10,578 | 9,485 | 4,296 | 8,053 |
| Accrued Expenses | 28,045 | 22,703 | 29,360 | 22,108 | 15,217 |
| Other current liabilities | 26,147 | 26,152 | 26,901 | 15,413 | 16,332 |
| TOTAL | $70,467 | $63,709 | $71,427 | $43,902 | $41,690 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 83 | 166 |
| Other Non-Current Liabilities | 83,681 | 85,844 | 97,522 | 65,882 | 66,218 |
| TOTAL | $83,681 | $85,844 | $97,522 | $65,882 | $66,218 |
| Total Liabilities | $154,148 | $149,553 | $168,949 | $109,784 | $107,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,613 | 121,385 | 120,895 | 108,898 | 108,659 |
| Common Shares | 121 | 121 | 121 | 109 | 109 |
| Retained earnings | -1,152,848 | -1,058,609 | -991,106 | -906,934 | -830,146 |
| Other shareholders' equity | -5,802 | -10,420 | -13,389 | -11,906 | -9,218 |
| TOTAL | $883,412 | $950,218 | $999,769 | $779,637 | $841,970 |
| Total Liabilities And Equity | $1,037,560 | $1,099,771 | $1,168,718 | $889,421 | $949,878 |